1. Home
  2. TRAK vs TTRX Comparison

TRAK vs TTRX Comparison

Compare TRAK & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRAK

ReposiTrak Inc.

HOLD

Current Price

$8.51

Market Cap

157.2M

Sector

Technology

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$8.07

Market Cap

281.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRAK
TTRX
Founded
1990
2015
Country
United States
United States
Employees
N/A
2
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.2M
281.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
TRAK
TTRX
Price
$8.51
$8.07
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
53.6K
128.5K
Earning Date
05-14-2026
05-31-2026
Dividend Yield
0.90%
N/A
EPS Growth
20.69
N/A
EPS
0.28
N/A
Revenue
$21,007,076.00
N/A
Revenue This Year
$6.61
N/A
Revenue Next Year
$10.04
N/A
P/E Ratio
$29.11
N/A
Revenue Growth
4.84
N/A
52 Week Low
$6.94
$2.57
52 Week High
$18.47
$11.69

Technical Indicators

Market Signals
Indicator
TRAK
TTRX
Relative Strength Index (RSI) 42.66 47.75
Support Level $8.11 $4.40
Resistance Level $9.09 $11.69
Average True Range (ATR) 0.28 1.04
MACD -0.06 -0.22
Stochastic Oscillator 51.81 4.52

Price Performance

Historical Comparison
TRAK
TTRX

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: